Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Mazerolles
Preclinical Toxicity, Toxicokinetics, and Antitumoral Efficacy Studies of DTS-201, a Tumor-Selective Peptidic Prodrug of Doxorubicin
Clinical Cancer Research
Cancer Research
Oncology
Related publications
OBI-3424, a Novel AKR1C3-activated Prodrug, Exhibits Potent Efficacy Against Preclinical Models of T-All
Clinical Cancer Research
Cancer Research
Oncology
Multimodality Imaging in Vivo for Preclinical Assessment of Tumor-Targeted Doxorubicin Nanoparticles
PLoS ONE
Multidisciplinary
Synthesis, Identification and in Vivo Studies of Tumor-Targeting Agent Peptide Doxorubicin (PDOX) to Treat Peritoneal Carcinomatosis of Gastric Cancer With Similar Efficacy but Reduced Toxicity
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Towards Prodrug-Nanomedicine Design
Molecular Pharmaceutics
Drug Discovery
Molecular Medicine
Pharmaceutical Science
Drug-Induced Physeal Abnormalities in Preclinical Toxicity Studies
Toxicologic Pathology
Forensic Medicine
Toxicology
Pathology
Cell Biology
Molecular Biology
Toxicokinetics and Time-Variable Toxicity of Cadmium inOppia nitensKoch (Acari: Oribatida)
Environmental Toxicology and Chemistry
Mutagenesis
Environmental Chemistry
Health
Toxicology
Preclinical Efficacy and Pharmacokinetics of AP5346, a Novel Diaminocyclohexane-Platinum Tumor-Targeting Drug Delivery System
Clinical Cancer Research
Cancer Research
Oncology
Preclinical Pharmacology and Pharmacokinetics of Inhaled Hexadecyl-Treprostinil (C16TR), a Pulmonary Vasodilator Prodrug
Journal of Pharmacology and Experimental Therapeutics
Molecular Medicine
Pharmacology
Anticancer Efficacy and Toxicokinetics of a Novel Paclitaxel-Clofazimine Nanoparticulate Co-Formulation
Drug Delivery and Translational Research
Pharmaceutical Science
